Navigation Links
Williamsburg, VA Tooth Loss Risk Can Be Reduced by Treating Infection with Laser Gum Disease Treatment Through Dr. Michael Schroer
Date:8/2/2013

Williamsburg, VA (PRWEB) August 02, 2013

Dr. Michael Schroer of Williamsburg Periodontics can offer a new solution for patients who may be in danger of tooth loss due to periodontal disease. The Laser Assisted New Attachment Procedure (LANAP), the only FDA-cleared gum disease treatment that uses a laser, is not only effective at treating periodontal disease, it has also been shown to stimulate bone, preventing loss of bone density and helping bone reattach to the teeth.

The laser used during LANAP, the Periolase MVP-7, offers patients many benefits. First, the laser has a stimulating effect on the bone, promoting growth and regeneration. This can be crucial for teeth that are already damaged, barely attached, and at risk of being lost. Furthermore, when teeth are lost, resorption, or loss of bone, can follow due to the loss of stimulation from the tooth. When Dr. Schroer uses the Periolase MVP-7 to stimulate the bone, it helps prevent loss of teeth and subsequent bone loss. Conventional periodontal surgery offers no similar mechanism for stopping tooth and bone loss. Traditional surgery does remove gum disease, but the procedure is highly invasive and results in the loss of healthy gum tissue that would normally stabilize and shield teeth.

Another advantage of LANAP is that the laser only targets bacteria and diseased tissue; its wavelength is not absorbed by water, teeth, roots, or gum tissue, so no unnecessary damage is caused during the procedure. Conventional surgery requires cutting and sutures; patients typically experience some pain and bleeding, and there is a potential for complications to develop after surgery. With LANAP, patients enjoy predictable results and a short recovery time. At the end of the procedure, the Periolase MVP-7 is used to create a blood clot at the base of the gum pocket, which essentially seals off the area that is healing. This ensures a more sterile environment for healing, reducing the likelihood of tooth loss and subsequent bone loss.

Even if LANAP cannot save every tooth, the other solutions that Dr. Schroer offers patients are more likely to be successful after LANAP has been performed. Patients who want to know more about this new gum disease treatment can visit http://www.williamsburgperiodontics.com or call the office for an appointment.

About the Practice:

Williamsburg Periodontics is a periodontal practice offering patients personalized dental care in Williamsburg, VA. Dr. Michael Schroer has been practicing dentistry for over 22 years. He received his undergraduate degree from the University of Missouri and he graduated from Dental School at the University of Missouri. He earned his degree in Periodontics from the University of North Carolina-Chapel Hill. Dr. Schroer is part of one percent of dental professionals providing the most recent FDA cleared laser procedure for gum disease and periodontal treatment. To learn more about Williamsburg Periodontics and their dental services visit their website at http://www.williamsburgperiodontics.com and call 757-645-9565.

Read the full story at http://www.prweb.com/releases/2013/8/prweb10994141.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Williamsburg, VA Periodontist, Dr. Michael Schroer, is Trained and Now Treating Patients with the Advanced Laser Gum Surgery for Gum Disease Treatment
2. Tooth Fairy “Kindness Kit” Wins 2012 Kids Product of the Year Award
3. Swallowed Toothpicks Can Lead to Big Trouble, Experts Warn
4. Clues to Ancient Dentistry Found in Human Tooth
5. Indesign, LLC Broadens Presence in Bluetooth with Bluetooth Low Energy - BLE
6. Company Announces Best Electric Toothbrush 2013
7. Zion Health Announces Native Remedy-Natural Clay Toothpaste without Fluoride formulated to help Prevent Gum Disease. Now Available At Whole Foods Market in Lafayette, CA.
8. Beta-catenin molecule is required for tooth root formation
9. Using mouthrinse reduces plaque and gingivitis more than toothbrushing alone
10. Tooth loss associated with cardiovascular risk factors in patients with chronic heart disease
11. Tooth Loss Associated With Higher Risk for Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... NEW YORK (PRWEB) , ... March 28, 2017 ... ... development, NTX Technology™, is the first technology to directly address the resolution to ... Organization. NTX Technology™ is a patented compound of FDA and TTB approved ingredients ...
(Date:3/28/2017)... ... ... Dr. Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts of ... Dr. Wentz talked about journey and research recently on a blog and discussed some ... only solution to deal with thyroid disease. , Dr. Wentz completed her graduation ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a ... Personal Emergency Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products are ... of their kind, the iSAFE and iSAFE Plus offer direct GPS Location and two-way ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... instruments are critical to ensuring high-quality results and maintaining GMP and USP compliance. ... Laboratory Instruments in accordance with GMP requirements " these requirements are explained. ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... corrosive ions found in power plant water and steam. , Chlorides and sulfates ... and boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ions at ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017  Medeon Biodesign, Inc., ... company, is pleased to announce that the Company ... of Panther Orthopedics, Inc., a San ... fixation solutions for orthopedic extremity applications.  ... expand rapidly, primarily due to procedure volume growth, ...
(Date:3/28/2017)... LONDON , March 28, 2017  "US ... insight on the various indicators and trend analysis ... generics drugs in mainstream pharmaceutical market in US. ... responsible for the growth on cancer generics drugs ... resulted in saving of billions of dollars for ...
(Date:3/28/2017)... 28, 2017  Orexigen Therapeutics, Inc. (Nasdaq: ... the fourth quarter and year ended December 31, 2016. ... transformational progress for Orexigen, beginning with the re-acquisition of ... early March, the team at Orexigen demonstrated remarkable focus, ... reshaped and strengthened our Company while rewarding us full ...
Breaking Medicine Technology: